WELUF's Net Loss Widens Amidst Declining Trust Account Interest

TL;DR

**WELUF is burning cash faster than it's earning interest, making its SPAC runway look increasingly short and risky.**

AI Summary

Integrated Wellness Acquisition Corp (WELUF) reported a net loss of $302,631 for the three months ended September 30, 2025, a significant increase from the $24,472 net loss in the prior year period. For the nine months ended September 30, 2025, the net loss was $619,485, compared to $139,980 in the same period of 2024. Total operating expenses for the nine months increased to $966,974 in 2025 from $1,720,919 in 2024, primarily due to a decrease in accounting and legal expenses from $1,127,079 to $406,775. Interest earned on cash held in the Trust Account decreased substantially, from $1,580,939 in the nine months ended September 30, 2024, to $347,489 in the same period of 2025. The company's total assets increased to $15,047,245 as of September 30, 2025, from $14,221,800 at December 31, 2024, driven by an increase in restricted cash and cash held in the Trust Account to $15,044,640. Total liabilities also rose to $12,696,752 from $11,341,823, largely due to an increase in accrued expenses to $2,491,816 and the promissory note to Suntone increasing to $3,676,223. The company continues to operate as a blank check company, with all activity related to its formation, IPO, and identifying a target for a Business Combination.

Why It Matters

For investors, WELUF's widening net loss and significant reduction in interest income from its Trust Account are critical indicators of its financial health and operational efficiency as a SPAC. The substantial decrease in interest earned, from $1,580,939 to $347,489 year-over-year, directly impacts the value available for redemptions and the company's ability to cover operating costs without further sponsor support. The increase in the promissory note to Suntone to $3,676,223 highlights the reliance on its new sponsor for funding, which could influence future business combination terms. In a competitive SPAC market, a declining cash yield and increasing liabilities could make WELUF less attractive to potential target companies and public shareholders, potentially impacting its ability to complete a successful business combination.

Risk Assessment

Risk Level: high — The company's net loss significantly increased to $619,485 for the nine months ended September 30, 2025, from $139,980 in the prior year, indicating a worsening financial position. Furthermore, interest earned on cash held in the Trust Account plummeted by 78% from $1,580,939 in 2024 to $347,489 in 2025, reducing the company's primary source of non-operating income. The promissory note to Suntone increased to $3,676,223, demonstrating growing reliance on sponsor funding to cover obligations.

Analyst Insight

Investors should exercise extreme caution and closely monitor WELUF's progress towards a business combination. Given the widening net loss and declining trust account interest, potential investors should avoid new positions until a definitive and financially viable target is announced, and existing investors should re-evaluate their holdings based on the increased financial risk.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$15,047,245

total Debt

$12,696,752

net Income

-$619,485

eps

N/A

gross Margin

N/A

cash Position

$0

revenue Growth

N/A

Key Numbers

• $619,485 — Net Loss (Increased from $139,980 in 2024 for the nine months ended September 30.)
• $347,489 — Interest Earned on Trust Account (Decreased significantly from $1,580,939 in 2024 for the nine months ended September 30.)
• $15,044,640 — Restricted Cash and Cash held in Trust Account (Increased from $14,215,318 at December 31, 2024.)
• $3,676,223 — Promissory Note – Suntone (Increased from $2,933,387 at December 31, 2024, indicating increased reliance on sponsor funding.)
• $12,696,752 — Total Liabilities (Increased from $11,341,823 at December 31, 2024.)
• $12,694,435 — Accumulated Deficit (Increased from $11,335,628 at December 31, 2024.)
• 1,185,481 — Class A ordinary shares outstanding (Consistent number of shares subject to possible redemption.)
• 2,875,000 — Class B ordinary shares outstanding (Consistent number of non-redeemable shares.)
• $966,974 — Total operating expenses (Decreased from $1,720,919 in 2024 for the nine months ended September 30, primarily due to lower accounting and legal fees.)
• $829,321 — Accretion of Class A ordinary shares subject to possible redemption (Non-cash financing activity for the nine months ended September 30, 2025.)

Key Players & Entities

• Integrated Wellness Acquisition Corp (company) — registrant
• Suntone Investment Pty Ltd (company) — Sponsor and promissory note holder
• Sriram Associates, LLC (company) — entity involved in Sponsor Handover
• IWH Sponsor LP (company) — Prior Sponsor
• SEC (regulator) — Securities and Exchange Commission
• $302,631 (dollar_amount) — net loss for Q3 2025
• $619,485 (dollar_amount) — net loss for nine months ended Sept 30, 2025
• $1,580,939 (dollar_amount) — interest earned on Trust Account for nine months ended Sept 30, 2024
• $347,489 (dollar_amount) — interest earned on Trust Account for nine months ended Sept 30, 2025
• $3,676,223 (dollar_amount) — promissory note to Suntone as of Sept 30, 2025

FAQ

Risk Factors

• Increased Net Loss and Accumulated Deficit [high — financial]: The company reported a net loss of $302,631 for the three months ended September 30, 2025, a significant increase from $24,472 in the prior year. For the nine months, the net loss was $619,485, up from $139,980. This has led to an accumulated deficit of $12,694,435 as of September 30, 2025, an increase from $11,335,628 at December 31, 2024.
• Decreased Interest Income from Trust Account [medium — financial]: Interest earned on the Trust Account decreased substantially from $1,580,939 in the nine months ended September 30, 2024, to $347,489 in the same period of 2025. This reduction in passive income impacts the company's ability to offset operating expenses.
• Growing Reliance on Promissory Notes [medium — financial]: The Promissory Note to Suntone increased to $3,676,223 as of September 30, 2025, from $2,933,387 at December 31, 2024. This indicates an increasing reliance on sponsor funding to cover operational needs.
• Blank Check Company Status and Business Combination Uncertainty [high — operational]: As a blank check company, Integrated Wellness Acquisition Corp's primary activity is identifying a target for a business combination. The success and timing of this combination are uncertain and critical for the company's future, with no specific target identified in the filing.
• Significant Increase in Accrued Expenses [medium — financial]: Accrued expenses rose to $2,491,816 as of September 30, 2025, from $1,943,887 at December 31, 2024. This increase in short-term obligations, alongside other liabilities, contributes to the overall financial strain.

Industry Context

Integrated Wellness Acquisition Corp operates within the Special Purpose Acquisition Company (SPAC) sector, which has seen significant activity but also increased scrutiny. The SPAC market is highly competitive, with numerous entities vying to identify and acquire promising targets, often in sectors like healthcare, technology, and consumer goods. Trends include a focus on specific niche industries and a growing emphasis on the target's long-term viability and growth potential post-combination.

Regulatory Implications

As a publicly traded entity, Integrated Wellness Acquisition Corp is subject to SEC regulations, including timely filing of financial reports (10-Q, 10-K) and adherence to accounting standards. The increasing net losses and reliance on sponsor financing could attract regulatory attention regarding financial stability and the viability of the business combination strategy. The redemption feature of Class A shares also presents a significant liquidity risk that regulators monitor.

What Investors Should Do

1. Monitor progress on identifying a business combination target.
2. Evaluate the sustainability of operating expenses relative to available capital.
3. Assess the terms and implications of the increasing promissory note from Suntone.
4. Understand the potential impact of redemptions on the Trust Account balance.

Key Dates

• 2025-09-30: Quarterly Report (10-Q) Filing — Provides updated financial performance and condition for the nine months ended September 30, 2025, highlighting increased losses and changes in liabilities.
• 2025-09-30: End of Reporting Period — Marks the end of the period for which financial statements are presented, showing a net loss of $619,485 for the nine months.
• 2024-09-30: Prior Year Reporting Period End — Used for comparison, showing a net loss of $139,980 for the nine months ended September 30, 2024, indicating a significant deterioration in performance.

Glossary

Blank Check Company

A shell corporation that is established to raise capital through an Initial Public Offering (IPO) for the purpose of acquiring an existing company. (Integrated Wellness Acquisition Corp operates as a blank check company, with all its activities focused on finding a target for a business combination.)

Business Combination

A merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business transaction involving one or more businesses. (The primary objective of Integrated Wellness Acquisition Corp is to identify and complete a business combination with a target company.)

Class A ordinary shares subject to possible redemption

Shares issued by the SPAC that holders can redeem for a pro rata share of the Trust Account if a business combination is not completed. (These shares represent a significant portion of the company's capital structure and are redeemable, impacting the net equity.)

Class B ordinary shares

Shares typically held by the sponsor, which are non-redeemable and often carry different voting rights or conversion features. (These shares represent the sponsor's stake and are not subject to redemption, unlike Class A shares.)

Trust Account

A segregated account holding the proceeds from the IPO, typically invested in U.S. Treasury bills or money market funds, to protect investor capital until a business combination is consummated. (The Trust Account holds the majority of the company's assets ($15,044,640) and generates interest income, which has significantly decreased.)

Accumulated Deficit

The cumulative net losses of a company that have not been offset by net income. (The accumulated deficit has increased to $12,694,435, reflecting the company's ongoing operational losses.)

Year-Over-Year Comparison

Compared to the prior year, Integrated Wellness Acquisition Corp has experienced a significant deterioration in financial performance. The net loss for the nine months ended September 30, 2025, increased by over 340% to $619,485 from $139,980 in the same period of 2024. This is primarily driven by a substantial decrease in interest earned on the Trust Account, which fell from $1,580,939 to $347,489. While total operating expenses decreased due to lower accounting and legal fees, the overall financial picture shows increased losses and a growing accumulated deficit, alongside a rise in liabilities, particularly the promissory note to Suntone.

Key Financial Figures

• $0.0001 — ,481 Class A ordinary shares, par value $0.0001 per share, and 2,875,000 Class B ordina

Filing Documents

• wel-20250930x10q.htm (10-Q) — 1020KB
• wel-20250930xex31d1.htm (EX-31.1) — 13KB
• wel-20250930xex32d1.htm (EX-32.1) — 8KB
• 0001104659-25-116051.txt ( ) — 4974KB
• wel-20250930.xsd (EX-101.SCH) — 44KB
• wel-20250930_cal.xml (EX-101.CAL) — 20KB
• wel-20250930_def.xml (EX-101.DEF) — 192KB
• wel-20250930_lab.xml (EX-101.LAB) — 276KB
• wel-20250930_pre.xml (EX-101.PRE) — 236KB
• wel-20250930x10q_htm.xml (XML) — 854KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 1 Item 1.

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 1 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited) 2 Condensed Consolidated Statements of Changes in Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 2024 (unaudited) 3 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (unaudited) 4 Notes to Condensed Consolidated Financial Statements (unaudited) 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 25 Item 4.

Controls and Procedures

Controls and Procedures. 25

– OTHER INFORMATION

PART II – OTHER INFORMATION 26 Item 1.

Legal Proceedings

Legal Proceedings 26 Item 1A.

Risk Factors

Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26 Item 3. Defaults Upon Senior Securities 26 Item 4. Mine Safety Disclosures 26 Item 5. Other Information 26 Item 6. Exhibits 27

SIGNATURES

SIGNATURES 28 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements INTEGRATED WELLNESS ACQUISITION CORP CONDENSED CONSOLIDATED BALANCE SHEETS September 30, December 31, 2025 2024 (unaudited) ASSETS Current assets Cash $ — $ 5,141 Due from related party 2,605 1,341 Total Current Assets 2,605 6,482 Non-current assets: Restricted Cash and Cash held in Trust Account 15,044,640 14,215,318 Total Non-current Assets 15,044,640 14,215,318 TOTAL ASSETS $ 15,047,245 $ 14,221,800 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT Current liabilities Accrued expenses $ 2,491,816 $ 1,943,887 Accounts payable 480,483 416,320 Due to related party 233,229 233,229 Promissory note – Suntone 3,676,223 2,933,387 Promissory note–related party 1,790,000 1,790,000 Total Current Liabilities 8,671,752 7,316,823 Non-current liabilities: Deferred underwriter's fee payable 4,025,000 4,025,000 Total Noncurrent Liabilities 4,025,000 4,025,000 Total Liabilities 12,696,752 11,341,823 Commitments and Contingencies (Note 5) Class A ordinary shares subject to possible redemption, $ 0.0001 par value; 1,185,481 shares issued and outstanding at redemption value 15,044,640 14,215,318 Shareholders' Deficit Preference shares, $ 0.0001 par value, 1,000,000 shares authorized; none issued and outstanding — — Class A ordinary shares subject to possible redemption, $ 0.0001 par value; 479,000,000 shares authorized; no shares issued and outstanding (excluding 1,185,481 shares subject to possible redemption) — — Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 2,875,000 shares issued and outstanding 288 288 Additional paid-in capital — — Accumulated deficit ( 12,694,435 ) ( 11,335,628 ) Total Shareholders' Deficit ( 12,694,147 ) ( 11,335,340 ) TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT

View Full Filing

View this 10-Q filing on SEC EDGAR